JPY 160.0
(-0.63%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -1.73 Billion JPY | -51.62% |
2022 | -1.14 Billion JPY | -31.91% |
2021 | -868 Million JPY | -24.0% |
2020 | -700 Million JPY | 32.63% |
2019 | -1.03 Billion JPY | -25.18% |
2018 | -830 Million JPY | -25.95% |
2017 | -659 Million JPY | 43.78% |
2016 | -1.17 Billion JPY | 9.29% |
2015 | -1.29 Billion JPY | 26.84% |
2014 | -1.76 Billion JPY | -53.01% |
2013 | -1.15 Billion JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -154 Million JPY | 82.09% |
2023 Q3 | -336 Million JPY | 66.67% |
2023 FY | -1.73 Billion JPY | -51.62% |
2023 Q1 | -308 Million JPY | 22.22% |
2023 Q4 | -860 Million JPY | -155.95% |
2023 Q2 | -1 Billion JPY | -227.27% |
2022 FY | -1.14 Billion JPY | -31.91% |
2022 Q3 | -307 Million JPY | -16.29% |
2022 Q4 | -396 Million JPY | -28.99% |
2022 Q2 | -264 Million JPY | -51.72% |
2022 Q1 | -174 Million JPY | 20.18% |
2021 Q4 | -218 Million JPY | -28.24% |
2021 Q2 | -197 Million JPY | 30.39% |
2021 Q3 | -170 Million JPY | 13.71% |
2021 FY | -868 Million JPY | -24.0% |
2021 Q1 | -283 Million JPY | -40.1% |
2020 FY | -700 Million JPY | 32.63% |
2020 Q3 | -136 Million JPY | -3.03% |
2020 Q1 | -230 Million JPY | 53.91% |
2020 Q2 | -132 Million JPY | 42.61% |
2020 Q4 | -202 Million JPY | -48.53% |
2019 Q4 | -499 Million JPY | -213.84% |
2019 Q2 | -208 Million JPY | -20.23% |
2019 Q1 | -173 Million JPY | 61.73% |
2019 FY | -1.03 Billion JPY | -25.18% |
2019 Q3 | -159 Million JPY | 23.56% |
2018 Q2 | -62 Million JPY | 70.05% |
2018 Q3 | -110 Million JPY | -77.42% |
2018 Q4 | -452 Million JPY | -310.91% |
2018 FY | -830 Million JPY | -25.95% |
2018 Q1 | -207 Million JPY | -224.87% |
2017 Q1 | -310.14 Million JPY | -47.5% |
2017 FY | -659 Million JPY | 43.78% |
2017 Q4 | 165.77 Million JPY | 321.03% |
2017 Q3 | -75 Million JPY | 35.9% |
2017 Q2 | -117 Million JPY | 62.28% |
2016 Q2 | -336.15 Million JPY | 6.17% |
2016 Q4 | -210.26 Million JPY | 21.38% |
2016 Q3 | -267.45 Million JPY | 20.44% |
2016 Q1 | -358.24 Million JPY | 16.73% |
2016 FY | -1.17 Billion JPY | 9.29% |
2015 FY | -1.29 Billion JPY | 26.84% |
2015 Q4 | -430.21 Million JPY | -29.89% |
2015 Q3 | -331.2 Million JPY | -57.62% |
2015 Q2 | -210.13 Million JPY | 34.45% |
2015 Q1 | -320.57 Million JPY | 44.56% |
2014 Q3 | -431.37 Million JPY | 1.23% |
2014 Q1 | -319.75 Million JPY | 41.7% |
2014 FY | -1.76 Billion JPY | -53.01% |
2014 Q4 | -578.22 Million JPY | -34.04% |
2014 Q2 | -436.75 Million JPY | -36.59% |
2013 FY | -1.15 Billion JPY | 0.0% |
2013 Q4 | -548.47 Million JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
DVx Inc. | 653.15 Million JPY | 365.788% |
Seikagaku Corporation | 433 Million JPY | 500.924% |
Eiken Chemical Co., Ltd. | 3.37 Billion JPY | 151.407% |
Create Medic Co., Ltd. | 803.24 Million JPY | 316.124% |
PHC Holdings Corporation | 8.31 Billion JPY | 120.885% |
Techno Medica Co., Ltd. | 1.84 Billion JPY | 194.336% |
Rion Co., Ltd. | 3.47 Billion JPY | 149.958% |
Nihon Kohden Corporation | 19.59 Billion JPY | 108.861% |
Fukuda Denshi Co., Ltd. | 26.5 Billion JPY | 106.549% |
Japan Lifeline Co., Ltd. | 10.89 Billion JPY | 115.938% |
Japan Medical Dynamic Marketing, INC. | 1.74 Billion JPY | 199.375% |
3-D Matrix, Ltd. | -2.11 Billion JPY | 17.999% |